Jane Street
VERA icon

Jane Street’s Vera Therapeutics VERA Stock Holding History

Jane Street’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,150
Closed -$788K – 13224
2026
Q1 		$851K Buy
+21,150
New +$911K ﹤0.01% 6869
2025
Q4 		– Sell
-13,042
Closed -$463K – 12482
2025
Q3 		$379K Buy
+13,042
New +$302K ﹤0.01% 8440
2025
Q2 		– Sell
-41,578
Closed -$935K – 10996
2025
Q1 		$999K Buy
+41,578
New +$1.34M ﹤0.01% 5578
2024
Q4 		– Sell
-46,420
Closed -$2.06M – 10678
2024
Q3 		$2.05M Sell
46,420
-101,555
-69% -$3.85M ﹤0.01% 4419
2024
Q2 		$5.35M Buy
147,975
+88,236
+148% +$3.5M ﹤0.01% 2877
2024
Q1 		$2.58M Buy
+59,739
New +$2.13M ﹤0.01% 3672
2023
Q4 		– Sell
-83,025
Closed -$1.14M – 9854
2023
Q3 		$1.14M Buy
83,025
+72,982
+727% +$1.25M ﹤0.01% 4985
2023
Q2 		$161K Sell
10,043
-9,256
-48% -$83.6K ﹤0.01% 7774
2023
Q1 		$150K Buy
+19,299
New +$149K ﹤0.01% 8014
2022
Q1 		– Sell
-8,287
Closed -$221K – 11075
2021
Q4 		$221K Buy
+8,287
New +$183K ﹤0.01% 8668

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street's VERA Position: Q2 2026 in Review

Jane Street sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 21,150 shares — an estimated $788K sold.

Jane Street first reported a position in VERA in Q4 2021 and held it in 10 quarters. The position peaked at $5.35M in Q2 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Jane Street reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 21,150 Vera Therapeutics shares in Q2 2026, an estimated $788K.
  • Jane Street first reported a position in Vera Therapeutics in Q4 2021 and held it in 10 quarters.
  • Jane Street's Vera Therapeutics position peaked at $5.35M in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.